Navigation Links
EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
Date:11/26/2012

160;       

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid® resulting in reduced royalty payments; risks associated with our product candidates; any early-stage products under development; results in preclinical models are not necessarily indicative of clinical results; uncertainties relating to preclinical and clinical trials, including delays to the commencement of such trials; the lack of success in the clinical development of any of our products; dependence on third parties; and risks relating to the commercialization, if any, of our proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks). Such factors, among others, could have a material adverse effect upon our busi
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
2. EntreMed Reports Second Quarter 2012 Financial Results
3. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
4. EntreMed Reports First Quarter 2012 Financial Results
5. Trovagene Announces Closing of Private Placement of $3.76 Million from the Sale of Restricted Common Stock and Warrants
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock
8. Vasomedical Announces Financial Results for the Third Quarter of 2012
9. Proteonomix, Inc. Announces Screening of Patients with End Stage Liver Disease in its Clinical Study of UMK-121
10. Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board
11. NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... interim chief executive officer Howie Rosen will ... financial officer Tim Morris will be presenting ... two presentations are as follows: Jefferies 2015 ...
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "North ... Replacement, Digit Replacement, Elbow Replacement, Hip Replacement, ... 2019" report to their offering. ,     ... replacement was valued at $4,470.9 million in ...
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jx648d/north_american ... "North American Active Wound Care Market by Method ... Ulcer), by End-User (In-Patient, & Out-Paient) - Analysis ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North American ... at a CAGR of 3.1% from 2014 to ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
... known as ED, erectile dysfunction is the ... erection for satisfactory sexual performance. ED affects an estimated ... most frequently in men who suffer from diabetes, high ... neurological diseases. However, according to Dr. Ridwan Shabsigh, director ...
... Mass. and SYDNEY, Sept. 15 HeartWare International, Inc. ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to make ... Sciences Conference on Tuesday, September 21, at 12:30 pm ...
Cached Medicine Technology:Men's Sexual Health and Medical Talk Show Expert Dr. Ridwan Shabsigh, MD Talks About How Erectile Dysfunction Affects Quality of Life 2Men's Sexual Health and Medical Talk Show Expert Dr. Ridwan Shabsigh, MD Talks About How Erectile Dysfunction Affects Quality of Life 3HeartWare to Present at the UBS 2010 Global Life Sciences Conference 2
(Date:5/23/2015)... (PRWEB) May 23, 2015 Add High-Quality prismatic ... Pixel Film Studios. , It's as simple as dragging and ... the included tool for full effect. , Including over ... high-dynamic range 5k sensors making this the ultimate bundle for ... flares included in this package are movie files designed for ...
(Date:5/22/2015)... Pioneer Millworks, the largest reclaimed wood ... designing with reclaimed wood, introducing their latest reclaimed wood ... Their newest offerings, Vat 35, Reclaimed Teak , ... to America's largest design event. , “Designers, architects, builders, ... anxious to see and feel the variety of wood ...
(Date:5/22/2015)... 2015 River Valley Health Partners (RVHP) ... health system’s Chief Financial Officer (CFO), will be leaving ... as the company CFO since 2011. , The Board ... the health system as CFO. Wesley will oversee the ... the Board of Trustees conducts a formal search for ...
(Date:5/22/2015)... Omar Ahmad Barrada, a junior at ... the 2015 Congress of Future Medical Leaders in Boston, ... of “America’s highest achieving high school students.” , “I’m ... new goals and learn better study habits,” said Omar. ... which we can ask the surgeons questions.” , The ...
(Date:5/22/2015)... “It’s like learning an new language,” ... President of Clinical Operations/Education and Training at Harmony ... how care is coded and reimbursed.” , Harmony ... reimbursement, operations and compliance consulting, as well as ... a new series of day-long seminars on the ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3
... Each year the American Institute of Biological ... outstanding contributions to the biological sciences. The ... pleased to announce the following award winners for ... Felsenstein, PhD, University of Washington, Outstanding Service Award: ...
... Quest Diagnostics Incorporated (NYSE: DGX ), ... services, announced that it is scheduled to speak at ... on Tuesday, May 19, 2009. The Quest Diagnostics ... Time.During the conference, the company will reaffirm its 2009 ...
... (OTC Bulletin Board: KDUS.OB) announced today financial results for ... the first quarter of 2009 were $100,000, compared to $100,000 ... the first quarter of 2009 decreased to $72,572, compared to ... 2008. The decrease in net loss can be principally ...
... two chemotherapy drugs with trastuzumab (Herceptin) to treat women ... another choice in their treatment options. , At the ... Clinical Oncology (ASCO), researchers from the Mayo ... combination of capecitabine, vinorelbine, and trastuzumab offers a treatment ...
... /PRNewswire-Asia-FirstCall/ --, - Third Quarter 2009 Revenue Increased 7.4% to ... $1.9 Million with EPS of $0.10, - Revenue for the ... Income Increased 29.2% to $5.7 Million with EPS of $0.23, ... - Cash Flow from Operations Increased 150.6% to $4.4 million ...
... China Medicine Corporation,(OTC Bulletin Board: CHME) (,China ... developer of prescription and over-the-counter pharmaceuticals,traditional Chinese ... medical formulations in the People,s Republic of ... received an award for ,Best,1000 Small & ...
Cached Medicine News:Health News:AIBS honors outstanding contributions to biology 2Health News:AIBS honors outstanding contributions to biology 3Health News:AIBS honors outstanding contributions to biology 4Health News:AIBS honors outstanding contributions to biology 5Health News:Quest Diagnostics to Speak at the Deutsche Bank 34th Annual Healthcare Conference 2Health News:Cadus Reports First Quarter 2009 Results 2Health News:Cadus Reports First Quarter 2009 Results 3Health News:Triple drug combination is promising option to treat metastatic HER2+ breast cancer 2Health News:Triple drug combination is promising option to treat metastatic HER2+ breast cancer 3Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 2Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 3Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 4Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 5Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 6Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 7Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 8Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 9Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 10Health News:Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results 11Health News:China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan 2Health News:China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan 3
... selecting an oxygen conserver, it's important to ... and budget. Now allied, a name synonymous ... Introducting Liberty™ and Mini Liberty™, two totally ... to provide extended battery life and powered ...
... Hudson RCI oxygen conserving ... "split prong" nose design ... tubes with standard connectors. ... utmost control and comfort ...
... Get the equivalent of 7.5 liters out ... will you need two machines for your high-flow ... OXYMIZER Disposable Oxygen-Conserving Devices function like standard conservers, ... flow of oxygen required to saturate a patient. ...
Proven and Efficient Stand-Alone Device. Offers a choice between alternate breath and every breath delivery. This model provides every breath delivery....
Medicine Products: